Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111252593 | 11125259 | 3 | F | 20061029 | 20160701 | 20150520 | 20160711 | EXP | PHEH2015US009123 | NOVARTIS | 61.59 | YR | F | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111252593 | 11125259 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | TABLET | QD | ||||||
| 111252593 | 11125259 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 600 MG, QD | 21588 | 600 | MG | TABLET | QD | ||||||
| 111252593 | 11125259 | 3 | C | VALIUM | DIAZEPAM | 1 | Unknown | 2 MG, UNK | U | 0 | 2 | MG | TABLET | ||||||
| 111252593 | 11125259 | 4 | C | XANAX | ALPRAZOLAM | 1 | Unknown | 0.5 MG, UNK | U | 0 | .5 | MG | TABLET | ||||||
| 111252593 | 11125259 | 5 | C | VITAMIIN C | ASCORBIC ACID | 1 | Unknown | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111252593 | 11125259 | 1 | Chronic myeloid leukaemia (in remission) |
| 111252593 | 11125259 | 3 | Product used for unknown indication |
| 111252593 | 11125259 | 4 | Product used for unknown indication |
| 111252593 | 11125259 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111252593 | 11125259 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111252593 | 11125259 | Balance disorder | |
| 111252593 | 11125259 | Blood pressure decreased | |
| 111252593 | 11125259 | Chest discomfort | |
| 111252593 | 11125259 | Dizziness | |
| 111252593 | 11125259 | Drug ineffective | |
| 111252593 | 11125259 | Fall | |
| 111252593 | 11125259 | Haemoglobin decreased | |
| 111252593 | 11125259 | Hip fracture | |
| 111252593 | 11125259 | Intervertebral disc protrusion | |
| 111252593 | 11125259 | Major depression | |
| 111252593 | 11125259 | Marrow hyperplasia | |
| 111252593 | 11125259 | Pain in extremity | |
| 111252593 | 11125259 | Palpitations | |
| 111252593 | 11125259 | Pulmonary mass | |
| 111252593 | 11125259 | Thinking abnormal | |
| 111252593 | 11125259 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111252593 | 11125259 | 1 | 2003 | 0 | ||
| 111252593 | 11125259 | 2 | 200506 | 201311 | 0 |